// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

PREDICTING RESPONSE TO ORAL CORTICOSTEROID INDUCTION THERAPY IN CHILDREN NEWLY DIAGNOSED WITH MODERATELY ACTIVE ULCERATIVE COLITIS: THE PROTECT STUDY

Sonia Davis - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Mesalamine

HIGHER MUCOSAL CALPROTECTIN EXPRESSION IS ASSOCIATED WITH INDUCTION OF ANTIMICROBIAL AND TUMOR NECROSIS FACTOR ALPHA SIGNALING AND REDUCED EFFECTIVENESS OF CORTICOSTEROID THERAPY IN TREATMENT NAIVE PEDIATRIC ULCERATIVE COLITIS

Phillip J. Dexheimer - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Mesalamine

PREVALENCE OF PSYCHIATRIC DISORDERS IS INCREASED FIVE YEARS BEFORE THE DIAGNOSIS IN IBD

John Walker - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

CONCOMITANT IMMUNOMODULATOR IS ASSOCIATED WITH A DECREASED RISK OF ANTI-TNF DISCONTINUATION AND SUBSTITUTION: A POPULATION BASED STUDY

Charles N. Bernstein - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methotrexate

PREDICTING RESPONSE TO MESALAMINE INDUCTION THERAPY IN CHILDREN NEWLY DIAGNOSED WITH MILD-TO-MODERATE ULCERATIVE COLITIS: THE PROTECT STUDY

Sonia Davis - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Mesalamine

SCREENING FOR NON-ALCOHOLIC FATTY LIVER DISEASE BY TRANSIENT ELASTOGRAPHY WITH CONTROLLED ATTENUATION PARAMETER IN UNSELECTED PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Chiara Saroli Palumbo - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

Methotrexate

GREATER CONTRIBUTION OF HLA TO RISK FOR PEDIATRIC-ONSET ULCERATIVE COLITIS CAN BE NARROWED TO 3 INDEPENDENT CLASSIC HLA VARIANTS AND CORRESPONDING AMINO ACID CHANGES

Suresh Venkateswaran - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

REDUCED TRANSCRIPTION OF GENES REGULATING MITOCHONDRIAL BIOGENESIS IS ASSOCIATED WITH POOR RESPONSE TO CORTICOSTEROID THERAPY IN NEWLY DIAGNOSED PEDIATRIC ULCERATIVE COLITIS

Phillip J. Dexheimer - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Mesalamine

PERIPHERAL ARTERIAL DISEASE IS ASSOCIATED WITH AN INCREASED RISK OF ELDERLY-ONSET INFLAMMATORY BOWEL DISEASE

Helena L. Chang - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

N/A

STUDIES USING HOSPITAL DISCHARGE DATABASES MAY UNDERESTIMATE OCCURRENCE OF CLOSTRIDIUM DIFFICILE INFECTIONS AMONG HOSPITALIZED INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE

Zoann Nugent - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

N/A

THE IMPACT OF PRIVATE INSURANCE ACCESS ON INFLAMMATORY BOWEL DISEASE-RELATED EMERGENCY DEPARTMENT USE

Geoffrey C. Nguyen - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

N/A

PROXIMAL DISEASE EXTENSION IN LIMITED ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Neeraj Narula - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

MICRORNA EXPRESSION PATTERNS ASSOCIATED WITH TISSUE LOCATION IN ENDOSCOPICALLY QUIESCENT Crohn's DISEASE VERSUS HEALTHY CONTROLS SUGGEST ALTERATIONS TO INNATE IMMUNOLOGICAL RESPONSE

Orlaith B. Kelly - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

N/A

CHARACTERIZING THE POST-TRANSFER PERIOD AMONGST PATIENTS WITH PEDIATRIC ONSET IBD: THE IMPACT OF ACADEMIC VS. COMMUNITY ADULT CARE ON EMERGENT HEALTH RESOURCE UTILIZATION

Anne M. Griffiths - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

Methadone hydrochloride

GENOME-WIDE ANALYSIS IDENTIFIES RARE COPY NUMBER VARIATIONS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE

Michael Sargent - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

MICROBIOME COMPOSITION IS ALTERED IN PATIENTS WITH IBD INDEPENDENT OF ENDOSCOPIC ACTIVITY

Williams Turpin - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

N/A

FUCOSYLTRANSFERASE 2 (FUT2) NON-SECRETOR STATUS IN Crohn's DISEASE: A PROSPECTIVE OBSERVATIONAL ANALYSIS

Uri Kopylov - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

ORAL ACETATE REDUCES A HIGH SUGAR DIET INDUCED INCREASED SUSCEPTIBILITY TO COLITIS

Amanpreet Gill - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Sodium Acetate

THE EFFECT OF VITAMIN D ON MACROPHAGE FUNCTION AND POLARIZATION IN Crohn's DISEASE

Carl-Frederic Duchatellier - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Ergocalciferol

THE NOVEL ROLE OF A SERPIN-PRODUCING PROBIOTIC IN GLUTEN-RELATED DISORDERS

Justin McCarville - Digestive Disease Week (DDW) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved